J Am Acad Audiol 2023; 34(09/10): 225-229
DOI: 10.1055/a-2165-0789
Case Report

Full Recovery of Sensorineural Hearing Loss in a Patient with Congenital Hypothyroidism

Jacline G. Phillips
1   Department of Otolaryngology–Head and Neck Surgery, Wake Forest School of Medicine, Winston-Salem, North Carolina
2   Department of Otolaryngology—Head and Neck Surgery, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina
,
Samantha B. Fabian
1   Department of Otolaryngology–Head and Neck Surgery, Wake Forest School of Medicine, Winston-Salem, North Carolina
2   Department of Otolaryngology—Head and Neck Surgery, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina
,
Erin W. Adkins
2   Department of Otolaryngology—Head and Neck Surgery, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina
,
Eleanor P. Kiell
1   Department of Otolaryngology–Head and Neck Surgery, Wake Forest School of Medicine, Winston-Salem, North Carolina
2   Department of Otolaryngology—Head and Neck Surgery, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina
› Author Affiliations

Abstract

Background: Congenital hypothyroidism (CH) is one of the most preventable causes of intellectual disability in the world. Screening programs have led to earlier detection of CH, and children with adequate thyroid supplementation can have minor long-term differences in overall neuropsychological testing compared to baseline.

Purpose: Despite early identification, up to one-fourth of children born with CH suffer from hearing loss even with early and adequate thyroid hormone supplementation. We present a unique case of an individual born with congenital hypothyroidism found to have sensorineural hearing loss.

Research Design: Case report.

Study Sample: Single subject.

Intervention: Diagnosis of congenital hypothyroidism at 1 week of life and initiation of treatment with levothyroxine.

Data Collection and Analysis: Degree of hearing loss was measured with age-appropriate audiological testing at ages 4 weeks, 7 weeks, 3 months, 7 months, 9 months, 11 months, and 12 months.

Results: The patient was treated early with thyroid hormone supplementation and demonstrated full recovery of hearing by age 12 months.

Conclusions: Despite the body of literature documenting hearing loss as an ongoing complication of CH, this patient demonstrates a unique case of full hearing recovery with early treatment.



Publication History

Received: 03 September 2022

Accepted: 25 August 2023

Accepted Manuscript online:
01 September 2023

Article published online:
12 December 2024

© 2024. American Academy of Audiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Wassner AJ. Pediatric hypothyroidism: diagnosis and treatment. Paediatr Drugs 2017; 19 (04) 291-301
  • 2 LaFranchi SH. Approach to the diagnosis and treatment of neonatal hypothyroidism. J Clin Endocrinol Metab 2011; 96 (10) 2959-2967
  • 3 Nelson HD, Bougatsos C, Nygren P. 2001 US Preventive Services Task Force. Universal newborn hearing screening: systematic review to update the 2001 US Preventive Services Task Force Recommendation. Pediatrics 2008; 122 (01) e266-e276
  • 4 Walsh JT. [R-NY-25] H.R.1193–Newborn and Infant Hearing Screening and Intervention Act of 1999. 106th Congress (1999–2000). Accessed October 29, 2024 at https://www.congress.gov/bill/106th-congress/house-bill/1193?r=97&s=1
  • 5 LaFranchi SH, Austin J. How should we be treating children with congenital hypothyroidism?. J Pediatr Endocrinol Metab 2007; 20 (05) 559-578
  • 6 Heuer H. Hear, hear! Thyroid hormone transporters in cochlear development. Endocrinology 2011; 152 (12) 4478-4480
  • 7 Deol MS. The role of thyroxine in the differentiation of the organ of Corti. Acta Otolaryngol 1976; 81 (5-6): 429-435
  • 8 Uziel A, Rabie A, Marot M. The effect of hypothyroidism on the onset of cochlear potentials in developing rats. Brain Res 1980; 182 (01) 172-175
  • 9 Cordas EA, Ng L, Hernandez A, Kaneshige M, Cheng SY, Forrest D. Thyroid hormone receptors control developmental maturation of the middle ear and the size of the ossicular bones. Endocrinology 2012; 153 (03) 1548-1560
  • 10 Rose SR, Brown RS, Foley T. et al; American Academy of Pediatrics, Section on Endocrinology and Committee on Genetics, American Thyroid Association, Public Health Committee, Lawson Wilkins Pediatric Endocrine Society. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006; 117 (06) 2290-2303
  • 11 Almagor T, Rath S, Nachtigal D. et al. High prevalence of hearing impairment in primary congenital hypothyroidism. Eur Thyroid J 2021; 10 (03) 215-221
  • 12 Gorga MP, Reiland JK, Beauchaine KA, Worthington DW, Jesteadt W. Auditory brainstem responses from graduates of an intensive care nursery: normal patterns of response. J Speech Hear Res 1987; 30 (03) 311-318
  • 13 Gorga MP, Kaminski JR, Beauchaine KL, Jesteadt W, Neely ST. Auditory brainstem responses from children three months to three years of age: normal patterns of response. II. J Speech Hear Res 1989; 32 (02) 281-288
  • 14 Perry R, Heinrichs C, Bourdoux P. et al. Discordance of monozygotic twins for thyroid dysgenesis: implications for screening and for molecular pathophysiology. J Clin Endocrinol Metab 2002; 87 (09) 4072-4077
  • 15 Grasberger H, Refetoff S. Genetic causes of congenital hypothyroidism due to dyshormonogenesis. Curr Opin Pediatr 2011; 23 (04) 421-428
  • 16 Ford G, LaFranchi SH. Screening for congenital hypothyroidism: a worldwide view of strategies. Best Pract Res Clin Endocrinol Metab 2014; 28 (02) 175-187
  • 17 Andrade CLO, Machado GC, Fernandes LDC. et al. Mechanisms involved in hearing disorders of thyroid ontogeny: a literature review. Arch Endocrinol Metab 2017; 61 (05) 501-505
  • 18 Wémeau JL, Kopp P. Pendred syndrome. Best Pract Res Clin Endocrinol Metab 2017; 31 (02) 213-224
  • 19 Ladsous M, Vlaeminck-Guillem V, Dumur V. et al. Analysis of the thyroid phenotype in 42 patients with Pendred syndrome and nonsyndromic enlargement of the vestibular aqueduct. Thyroid 2014; 24 (04) 639-648
  • 20 Heinen CA, Losekoot M, Sun Y. et al. Mutations in TBL1X are associated with central hypothyroidism. J Clin Endocrinol Metab 2016; 101 (12) 4564-4573
  • 21 Mohiyuddin SA, Apoorva HM, Prasad KN, Munikrishna N. Hearing outcome in infants following correction of maternal hypothyroidism during pregnancy. Int J Pediatr Otorhinolaryngol 2021; 142: 110597
  • 22 Braga H, Duarte JL, da Cruz Fernandes L. et al. Congenital hypothyroidism as a risk factor for hearing and parents' knowledge about its impact on hearing. J Otol 2021; 16 (02) 71-79
  • 23 Fan Y, Niu X, Chen Y, Ping L, Yang T, Chen X. Long-term evaluation of development in patients with bilateral microtia using softband bone conducted hearing devices. Int J Pediatr Otorhinolaryngol 2020; 138: 110367
  • 24 Lichtenberger-Geslin L, Dos Santos S, Hassani Y, Ecosse E, Van Den Abbeele T, Léger J. Factors associated with hearing impairment in patients with congenital hypothyroidism treated since the neonatal period: a national population-based study. J Clin Endocrinol Metab 2013; 98 (09) 3644-3652
  • 25 Bruno R, Aversa T, Catena M. et al. Even in the era of congenital hypothyroidism screening mild and subclinical sensorineural hearing loss remains a relatively common complication of severe congenital hypothyroidism. Hear Res 2015; 327: 43-47
  • 26 Chou YH, Wang PJ. Auditory brainstem evoked potentials in early-treated congenital hypothyroidism. J Child Neurol 2002; 17 (07) 510-514
  • 27 Singh R, Aftab M, Jain S, Kumar D. Audiological evaluation in hypothyroid patients and effect of thyroxine replacement therapy. Indian J Otolaryngol Head Neck Surg 2019; 71 (Suppl. 01) 548-552